Investor Presentaiton
ersonal use only
Partnering to drive growth in clinical sites
Imricor entered into a number of agreements in 2020 that promote future iCMR lab adoption
•
•
PHILIPS Sana
A worldwide leading
manufacturer of MRI
equipment
Non-exclusive collaborative
sales distribution agreement
Enables the sale of Imricor's
capital product, Advantage-MR
EP Recorder/Stimulator
System as part of Philips
comprehensive iCMR lab
installation package¹
Enables the extensive Philips
sales force to drive iCMR lab
adoption
Imricor continues to be the
exclusive provider of its
consumable devices
•
Einkauf & Logistik
Largest Group Purchasing
Organisation in Germany, with
600 cooperating hospitals and
medical institutions across
Germany & Switzerland
Imricor products included in
approved catalogue,
establishing pricing and
eliminating time consuming
contract negotiations
Streamlines access to ~80 sites
that perform cardiac ablations
for sales and marketing
activities
.
.
.
Opto
acoustics
Leading provider of innovative
optical communication
solutions for MRI applications
Facilitates the introduction of
the IMROCTM Wireless
Multichannel Communication
System to Imricor customers
Innovative noise cancelling
communication technology
supporting iCMR adoption
Establishes an important sales
channel ensuring availability
as new sites are launched
Referral fee-based agreement
•
OSYPKA
Technology for an active life
Leading German producer of
radiofrequency ablation
generators
Under the agreement Imricor
will sell Osypka's HAT 500
radiofrequency ablation
generator system to customers
for use in iCMR ablation
procedures
The HAT 500 is compatible
with Imricor's Advantage-MR
EP Recorder/Stimulator,
replacing the discontinued
Abbott IBI T11 ablation
generator.
12
1. In European countries that recognise the CE mark
Imricor FY20 Investor Presentation, February 2021View entire presentation